Endothelin-1 (ET-1) and Nerve Growth Factor (NGF) are proteins, released from cancer-ridden tissues, which cause spontaneous pain and hypersensitivity to noxious stimuli. Here we examined the electrophysiological and behavioral effects of these two agents for evidence of their interactions. Individual small-medium cultured DRG sensory neurons responded to both ET-1 (50 nM, n=6) and NGF (100 ng/ml, n=4), with increased numbers of action potentials and decreased slow K(+) currents; pre-exposure to ET-1 potentiated NGF´s actions, but not vice versa. Behaviorally, single intraplantar (i.pl.) injection of low doses of ET-1 (20 pmol) or NGF (100 ng), did not increase hindpaw tactile or thermal sensitivity, but their simultaneous injections sensitized the paw to both modalities. Daily i.pl. injections of low ET-1 doses in male rats caused tactile sensitization after 21 days, and enabled further tactile and thermal sensitization from low dose NGF, in ipsilateral and contralateral hindpaws. Single injections of 100 ng NGF, without changing the paw's tactile sensitivity by itself, acutely sensitized the ipsilateral paw to subsequent injections of low ET-1. The sensitization from repeated low ET-1 dosing and the cross-sensitization between NGF and ET-1 were both significantly greater in female than in male rats. These findings reveal a synergistic interaction between cutaneously administered low doses of NGF and ET-1, which could contribute to cancer-related pain.

Department of Pharmacology and Toxicology Indiana University School of Medicine Indianapolis IN USA

Pain Research Center Department of Anesthesiology Perioperative and Pain Medicine Brigham and Women's Hospital Harvard Medical School Boston MA USA

000      

00000naa a2200000 a 4500

001      

bmc19005325

003      

CZ-PrNML

005      

20210531151223.0

007      

ta

008      

190204s2018 xr d f 000 0|eng||

009      

AR

024    7_

$a 10.33549/physiolres.933819 $2 doi

035    __

$a (PubMed)29947541

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xr

100    1_

$a Khodorova, A. $u Pain Research Center, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

245    10

$a Interactions of peripheral endothelin-1 and nerve growth factor as contributors to persistent cutaneous pain / $c A. Khodorova, Y. Zhang, G. Nicol, G. Strichartz

520    9_

$a Endothelin-1 (ET-1) and Nerve Growth Factor (NGF) are proteins, released from cancer-ridden tissues, which cause spontaneous pain and hypersensitivity to noxious stimuli. Here we examined the electrophysiological and behavioral effects of these two agents for evidence of their interactions. Individual small-medium cultured DRG sensory neurons responded to both ET-1 (50 nM, n=6) and NGF (100 ng/ml, n=4), with increased numbers of action potentials and decreased slow K(+) currents; pre-exposure to ET-1 potentiated NGF´s actions, but not vice versa. Behaviorally, single intraplantar (i.pl.) injection of low doses of ET-1 (20 pmol) or NGF (100 ng), did not increase hindpaw tactile or thermal sensitivity, but their simultaneous injections sensitized the paw to both modalities. Daily i.pl. injections of low ET-1 doses in male rats caused tactile sensitization after 21 days, and enabled further tactile and thermal sensitization from low dose NGF, in ipsilateral and contralateral hindpaws. Single injections of 100 ng NGF, without changing the paw's tactile sensitivity by itself, acutely sensitized the ipsilateral paw to subsequent injections of low ET-1. The sensitization from repeated low ET-1 dosing and the cross-sensitization between NGF and ET-1 were both significantly greater in female than in male rats. These findings reveal a synergistic interaction between cutaneously administered low doses of NGF and ET-1, which could contribute to cancer-related pain.

650    _2

$a zvířata $7 D000818

650    _2

$a endotelin-1 $x aplikace a dávkování $x metabolismus $x toxicita $7 D019332

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a injekce subkutánní $7 D007279

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a nervový růstový faktor $x aplikace a dávkování $x metabolismus $x toxicita $7 D020932

650    _2

$a bolest $x chemicky indukované $x metabolismus $7 D010146

650    _2

$a měření bolesti $x metody $7 D010147

650    _2

$a fyzikální stimulace $x škodlivé účinky $7 D010812

650    _2

$a vazba proteinů $x fyziologie $7 D011485

650    _2

$a krysa rodu Rattus $7 D051381

650    _2

$a potkani Sprague-Dawley $7 D017207

650    _2

$a hmat $x účinky léků $x fyziologie $7 D014110

655    _2

$a časopisecké články $7 D016428

700    1_

$a Zhang, Y. $u Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA

700    1_

$a Nicol, G. $u Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA

700    1_

$a Strichartz, G. $u Pain Research Center, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

773    0_

$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 67, Suppl. 1 (2018), s. S215-S225

773    0_

$t ET-15 $g (2018), s. S215-S225 $w MED00206979

856    41

$u https://pubmed.ncbi.nlm.nih.gov/29947541 $y Pubmed

910    __

$a ABA008 $b A 4120 $c 266 $y 4 $z 0

990    __

$a 20190204 $b ABA008

991    __

$a 20210531151223 $b ABA008

999    __

$a ok $b bmc $g 1376288 $s 1043530

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2018 $b 67 $c Suppl. 1 $d S215-S225 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824

BMC    __

$a 2018 $d S215-S225 $m ET-15 $x MED00206979

LZP    __

$b NLK118 $a Pubmed-20190204